Reactive oxygen species (ROS) are highly reactive compounds produced by the electron transport chain in mitochondria and various enzymes like NADPH oxidase.While balanced ROS are crucial for cell survival and function, an imbalance can lead to cellular damage, particularly affecting DNA, which may induce mutations linked to cancer.Interestingly, elevated ROS levels can trigger apoptosis in cancer cells, presenting a therapeutic opportunity to enhance treatment responses in therapies such as chemotherapy and radiation.This review discusses the dual role of ROS in healthy versus cancerous cells and highlights current drugs like IACS-010,759, VLX600, and GBS-01 developed for ROS-based treatment strategies.It emphasizes the need for more targeted approaches to maximize therapeutic efficacy while minimizing harm to healthy cells.